CNTB
Price
$1.17
Change
+$0.09 (+8.33%)
Updated
Jul 3 closing price
Capitalization
64.97M
THAR
Price
$1.86
Change
+$0.04 (+2.20%)
Updated
Jul 3 closing price
Capitalization
7.83M
Interact to see
Advertisement

CNTB vs THAR

Header iconCNTB vs THAR Comparison
Open Charts CNTB vs THARBanner chart's image
Connect Biopharma Holdings
Price$1.17
Change+$0.09 (+8.33%)
Volume$148.66K
Capitalization64.97M
Tharimmune
Price$1.86
Change+$0.04 (+2.20%)
Volume$12.48K
Capitalization7.83M
CNTB vs THAR Comparison Chart in %
Loading...
CNTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNTB vs. THAR commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTB is a Buy and THAR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (CNTB: $1.17 vs. THAR: $1.86)
Brand notoriety: CNTB and THAR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTB: 176% vs. THAR: 18%
Market capitalization -- CNTB: $64.97M vs. THAR: $7.83M
CNTB [@Biotechnology] is valued at $64.97M. THAR’s [@Biotechnology] market capitalization is $7.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTB’s FA Score shows that 1 FA rating(s) are green whileTHAR’s FA Score has 1 green FA rating(s).

  • CNTB’s FA Score: 1 green, 4 red.
  • THAR’s FA Score: 1 green, 4 red.
According to our system of comparison, both CNTB and THAR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTB’s TA Score shows that 4 TA indicator(s) are bullish while THAR’s TA Score has 4 bullish TA indicator(s).

  • CNTB’s TA Score: 4 bullish, 3 bearish.
  • THAR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CNTB is a better buy in the short-term than THAR.

Price Growth

CNTB (@Biotechnology) experienced а +20.48% price change this week, while THAR (@Biotechnology) price change was +5.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNTB($65M) has a higher market cap than THAR($7.83M). THAR YTD gains are higher at: -8.374 vs. CNTB (-15.268). THAR has higher annual earnings (EBITDA): -12.47M vs. CNTB (-20.6M). CNTB has more cash in the bank: 84M vs. THAR (1.08M). THAR has less debt than CNTB: THAR (271K) vs CNTB (940K). CNTB has higher revenues than THAR: CNTB (26M) vs THAR (0).
CNTBTHARCNTB / THAR
Capitalization65M7.83M830%
EBITDA-20.6M-12.47M165%
Gain YTD-15.268-8.374182%
P/E RatioN/A0.02-
Revenue26M0-
Total Cash84M1.08M7,807%
Total Debt940K271K347%
TECHNICAL ANALYSIS
Technical Analysis
CNTBTHAR
RSI
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
87%
MACD
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
N/A
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CNTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACRFF53.10N/A
N/A
Accor SA Ltd.
APELY20.36N/A
N/A
Alps Alpine Co Ltd.
DGDCF0.10N/A
N/A
Dynasty Gold Corp.
TKCOF43.45N/A
N/A
Toho Co., Ltd.
NLST0.64-0.02
-2.53%
Netlist, Inc.

CNTB and

Correlation & Price change

A.I.dvisor tells us that CNTB and ABCZF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNTB and ABCZF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTB
1D Price
Change %
CNTB100%
+8.27%
ABCZF - CNTB
28%
Poorly correlated
N/A
THAR - CNTB
25%
Poorly correlated
+2.20%
RANI - CNTB
25%
Poorly correlated
+0.68%
VERA - CNTB
23%
Poorly correlated
+1.48%
ALDX - CNTB
23%
Poorly correlated
+7.50%
More

THAR and

Correlation & Price change

A.I.dvisor indicates that over the last year, THAR has been closely correlated with CDTX. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if THAR jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THAR
1D Price
Change %
THAR100%
+2.20%
CDTX - THAR
82%
Closely correlated
+1.90%
NBY - THAR
81%
Closely correlated
+0.62%
RNAC - THAR
81%
Closely correlated
-1.41%
NCNA - THAR
81%
Closely correlated
-5.13%
WINT - THAR
80%
Closely correlated
N/A
More